NCT07607054 2026-05-26A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.Shanghai EpimAb Biotherapeutics Co., Ltd.Phase 1 Not yet recruiting50 enrolled